Anti-bribery and Anticorruption

• Conducted internal investigations of potential liability under the US Foreign Corrupt Practices Act (FCPA) and local anticorruption rules involving:
• hiring of relatives of politically connected persons by a financial institution in China.
• clinical trials in China by a pharmaceutical company.
• use of intermediaries by a financial institution in Indonesia.
• marketing and customs clearance practices of a US issuer’s operations in Singapore, China, Indonesia, and Malaysia.

Fraud and Corporate Misconduct

• Advised a financial institution in connection with a Monetary Authority of Singapore investigation into misconduct by foreign exchange and interest rate traders.

Antitrust and Competition

• Represented Time Warner in Chinese merger review of its USD85 billion purchase by AT&T.
• Represented major Asian semiconductor company in multi-jurisdictional opposition to a merger of top two manufacturers of semiconductor fabrication equipment, leading to abandonment of the transaction due to objections from competition authorities.
• Advised hard-drive manufacturer in obtaining conditional clearance of acquisition of competitor in China.
• Advised US entertainment company on antitrust and other regulatory issues regarding strategic joint venture with Chinese entertainment company.

International Trade, Sanctions and Export Controls

• Represented US publishing company challenging Chinese restrictions on market access for foreign publishers and publications in support of successful US claims before WTO panel and WTO Appellate Body.